Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

Cohance Lifesciences Results Update

Cohance Lifesciences reported Q1FY27 revenue from operations of ₹4,223 million, down 23.1% year-on-year. The company noted weak performance and expects improvement in the second half.

Source

NSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cohance Lifesciences Ltd: key numbers

Share price
₹450.45
Market cap
₹17,234 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
162.2×Sector 37.9×
Promoter holding
57.48%-0.01% QoQ
FII holding
7.71%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cohance Lifesciences Ltd

All →

Other results update announcements

All →